Bristol-Myers Squibb Stock Forecast

Evaluation of Bristol-Myers Squibb stock downgraded after the last trading session.
(Updated on Apr 24, 2024)

BMY Signals & Forecast

There are mixed signals in the stock today. The Bristol-Myers Squibb stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $51.36. On a fall, the stock will find some support from the short-term average at $48.62. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 2.13%. Further rise is indicated until a new top pivot has been found.

Support, Risk & Stop-loss for Bristol-Myers Squibb stock

Bristol-Myers Squibb finds support from accumulated volume at $48.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.490 between high and low, or 1.01%. For the last week, the stock has had daily average volatility of 1.41%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BMY) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Bristol-Myers Squibb Company to open at $48.82, and during the day (based on 14 day Average True Range), to move between $48.01 and $49.71, which gives a possible trading interval of +/-$0.85 (+/-1.74%) up or down from last closing price. If Bristol-Myers Squibb Company takes out the full calculated possible swing range there will be an estimated 3.49% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $48.71 (0.31%) than the resistance at $49.86 (2.05%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Bristol-Myers Squibb Company stock A Buy?

Bristol-Myers Squibb holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.145 Sell Candidate Downgraded

Predicted Opening Price for Bristol-Myers Squibb Company of Thursday, April 25, 2024

The predicted opening price is based on yesterday's movements between high, low, and closing price.